The human foamy virus internal promoter is required for efficientgene expression and infectivity  by Löchelt, Martin et al.
VIROLOGY 206, 601--610 (1995) 
The Human Foamy Virus Internal Promoter Is Required for Efficient 
Gene Expression and Infectivity 
MARTIN LOCHELT, SHUYUARN F. YU,* MAXINE L. LINIAL,* AND ROLF M. FLUGEL 1 
Abteilung Retrovirale Genexpression, Forschungsschwerpunkt Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, 
Im Neuenheimer Feld 242, 69009 Heidelberg, Germany, and *Division of Basic Sciences, Fred Hutchinson 
Cancer Researbh Center, 1124 Columbia Street, Sea#le, Washington 98104-2092 
Received August 2, 1994; accepted October 25, 1994 
The human foamy or spumaretrovirus (HFV) is a complex retrovirus that codes for the three retroviral genes gag, pol, 
and env and the regulatory and accessory bel genes. A particular feature of HFV gene expression was recently described: 
not only does the HFV provirus contain the classical retroviral long terminal repeat promoter, a second functionally active 
promoter is present in the envgene upstream of the be/genes (M. L6chelt, W. Muranyi, and R. M. FDgel, 1993, Prec. Natl. 
Acad. Sci. USA 90, 7317-7321). Both, the HFV long terminal repeat promoter 1 and internal promoter II depend upon the 
HFV transcriptional transactivator Bel 1 for efficient gene expression. The internal promoter directs the synthesis of function- 
ally active Bel 1 transactivator and Bet proteins that are expressed early after HFV infection. In this report, it is shown that 
mutation of the promoter IITATA box resulted in HFV proviral clones with a reduction in infectivity by a factor of approximately 
100. Gene expression by promoter II TATA box mutant HFV proviruses was reduced. HFV proviruses with the mutated 
promoter II TATA box used cryptic start sites of transcription upstream of the original promoter II TATA box, resulting in 
an inefficient and less accurate transcriptional initiation. The reduced HFV structural gene expression by the mutated HFV 
proviruses was relieved by providing Bel 1 protein in trans. This demonstrates that HFV promoter II-directed Bel 1 expression 
is important for producing the high levels of Bel 1 that increases virus replication. © 1995 Academic Press, Inc. 
INTRODUCTION 
The human foamy or spumaretrovirus (HFV) is an exog- 
enous and complex retrovirus isolated from the lympho- 
blastoid cells of a nasopharyngeal carcinoma patient 
(Achong eta/., 1971). The HFV genome (Fig. 1A) encodes 
regulatory and accessory be/genes  that are located 3' 
of env (FlOgel et aL, 1987; Maurer et al., 1988; Muranyi 
and FI0gel, 1991; Weissenberger and FIQgel, 1994). The 
Bel 1 protein is a transcriptional transactivator for the 
long terminal repeat (LTR) promoter I and the internal 
promoter II and is absolutely required for viral replication 
and gene expression (Keller et aL, 1991; Lee et aL, 1993; 
Rethwilm et aL, 1991; Venkatesh et aL, 1991; L6chelt et 
a/., 1991, 1993a, 1994; Baunach eta/., 1993; Yu and Linial, 
1993). A complex genomic organization, the existence of 
the taf transactivator, and the presence of an internal 
promoter corresponding to that described for HFV were 
recently reported for the closely related simian foamy 
virus type 1 (Mergia et aL, t990, 1991; Mergia and Luciw, 
1991; Mergia, 1994; Campbell et aL, 1994). Internal pro- 
moters are not restricted to foamy viruses, since an inter- 
nal promoter for Tax transactivator expression was re- 
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cently reported for human T-ceil lymphotropic virus type 
I (Nosaka et aL, 1993). 
The existence of the internal promoter II adds another 
level of complexity to HFV gene expression. Both, singly 
and multiply spliced transcripts are derived from the LTR 
promoter I and the internal promoter II (Muranyi and 
FIQgel, 1991; LOchelt et aL, 1993a, 1994). The internal 
cap site at HFV nucleotide (nt) 9196 is located upstream 
of the be/genes  in the 3' end of the env gene (LOchelt 
etaL, 1993a) (Figs. 1A and 1B). The promoter II is strongly 
Bel 1 transactivator-dependent like the HFV LTR pro- 
moter I. It is likely that there is a mutual interdependence 
of both HFV promoters in the provirus, since the basal 
activity of the internal promoter is increased by the pres- 
ence of the LTR promoter in cis in reporter gene con- 
structs containing both promoters (L6chelt eta/., 1993b). 
In this study, the HFV promoter II TATA box was mutated 
and the effects on gene expression and infectivity were 
analyzed. The resulting proviral DNA clone exhibited a 
greatly reduced infectivity when compared to the wild- 
type provirus. Furthermore, the expression of the HFV 
genes was reduced. The reduction of HFV structural 
gene expression by promoter II TATA box mutant provi- 
ruses could be compensated by coexpression of Bel 1. 
The experiments presented demonstrate that the HFV 
promoter II plays an important role early in HFV gene 
expression and infectivity by providing Bel 1 transactiva- 
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tor protein necessary for viral gene expression and in- 
fectivity. 
MATERIALS AND METHODS 
Plasmids used 
The infectious HFV DNA clone pHSRV13 served as 
source of viral DNA (LOchelt et a/., 1991); nucleotide num- 
bering starts at the first base of the 5' LTR of the HFV 
provirus. Plasmids pOMV/3gal, pCMVSEAP,, and pOMVluc 
(Butz and Hoppe-Seyler, 1993; L6chelt et al., 1993a,b) di- 
rect the expression of /~-galactosidase (/~-gal), the se- 
creted form of the human alkaline phosphatase (SEAP), 
and the firefly luciferase (luc) gene from the cytomegalovi- 
rus immediate-early (CMV-IE) promoter. Indicator gene 
plasmid pNNSEAP+ contains the internal promoter/en- 
hancer (HFV nt 8971 to 9253) in the sense orientation 
upstream of the SEAP gene, respectively (LOchelt et aL, 
1993a). Bel 1 expression clones pBCbel, pBCbell, and 
pbells and the parental pBC12CMV vector were de- 
scribed recently (Keller eta/., 1991; Venkatesh eta/., 1993; 
L6chelt eta/., 1994). 
Construction of recombinant clones 
Molecular cloning was performed according to standard 
techniques (Sambrook et al., 1989). Indicator gene constructs 
containing a mutated TATA box were constructed by poly- 
merase chain reaction (POR)-directed mutagenesis as de- 
scribed (Butz and Hoppe-Seyler, 1993). Plasmid pNNSEAP+ 
was used as template for PCRs with primers 8971s (LOchelt 
et al., 1993a) plus z~TATAa (5'-TGCTCCqq-GATCGATTCT- 
CCAGAGGATGTG-3') plus SEAPan (LOchelt et al., 1993a) 
plus ATATAs (5'-GAGAATCGATOAAGGAGCAGA-I-I-GAAA- 
GAG-3'). The reaction products corresponding to HFV nt 
8971 to the mutated TATA box and those starting at the 
mutated TATA box and extending to the SEAP gene were 
gel-purified and identical concentrations were combined for 
PCR amplification with primers 8971s and SEAPan. The reac- 
tion product of 321 nt was blunt-ended with T4 DNA polymer- 
ase and digested with Sphl, which cleaved at the initiator 
codon of the SEAP gene. The gel-purified DNA fragment 
from HFV nt 8971 to the SEAP leader sequence was inserted 
between the EcoRV and the Sphl sites of plasmid pPLSEAP 
(Keller et al., 1991), resulting in the pNNSEAP+ derivative 
pNNSEAPmTATA that contains a mutated TATA box (mu- 
tated from 5'-AAAGTATAAAA-3' to 5'-AATCGATCAAG-3', 
TATA box underlined, mutations are shown in bold face 
letters; Figs. 1B and 1D). Piasmid pNNSEAPmTATA was 
sequenced, demonstrating that the HFV insert corresponded 
to the original sequence except for the mutations given 
above. The mutated HFV DNA was also transferred into 
plasmid pBLCAT6 (Boshart et al., 1992) to yield clone 
pN NCATmTATA. 
The mutated TATA box of plasmid pNNSEAPmTATA 
was inserted into the infectious HFV DNA clone 
pHSRV13. Plasmid pNNSEAPmTATA was digested with 
Maell  (HFV nt 9004) and Cell l  (HFV nt 9194) and the 190- 
nt HFV DNA fragment containing the mutated TATA box 
was inserted into the corresponding restriction sites in 
pHSRV13. The identity of two independent recombinant 
clones, pHSRVmTATA7 and pHSRVmTATA19, was con- 
firmed by restriction analysis and DNA sequencing. 
A deletion mutant of pHSRV13 lacking the central do- 
main of envwas  constructed by digesting pHSRV13 DNA 
with Mrol and Ndel. The 13.4-kb DNA fragment lacking 
HFV env sequences from nt 6962 to 8970 was blunt- 
ended and religated. The resulting clone pHSRV2~MN 
lacked 2011 nt of the env gene but contained the intact 
internal promoter II (Fig. 1F). 
Cell culture 
0OS7 and human embryonic lung (HEL) cells were 
grown and virus infections were done as described (LO- 
chelt et aL, 1991). The HFV indicator cell line FAB was 
cultured as described (Yu and Linial, 1993). Cell-associ- 
ated and cell-free HFV particles were harvested and HFV 
titrations on FAB cells were performed as described ex- 
cept that FAB cells were grown on 24-well plates (Yu 
and Linial, 1993). 
DNA transfection and expression assays 
Transfections by electroporation of 10 fig DNA and 
reporter gene assays were performed and quantitated 
as described previously (Keller et aL, 1991; LOchelt et aL, 
1991, 1993a). For iuc assays, cells were harvested 42 hr 
after transfection in luc buffer (25 mM Tris/HOl, pH 7.8, 
4 mM EGTA, 10% glycerol, and 1% Triton X-100) and 
insoluble material was sedimented at 12,000 g at 4 ° 
(Hdppe-Seyler et aL, 1991). The supernatant was used 
for luc, fl-gal, and radioimmunoprecipitation assays 
(RIPA) or precipitated with ethanol for immunoblotting 
(Western blotting). 
Immunological techniques 
The preparation of cell-associated antigen, protein 
blotting (Western blots), and sera used were described 
previously (Bartholom~ et aL, 1992; LOchelt et aL, 1991, 
1994; Mahnke et aL, 1990). RIPAs were performed using 
the cleared luc lyates that were adjusted with the same 
volume of 10 mM Tris/HCI, pH 7.5, 300 mM NaCI, 1% 
Triton X-100, 1% deoxycholate, 2 mM EDTA, and 0.2% 
SDS to standard RIPA conditions (Sambrook eta/., 1989). 
Antigen lysates (250 #1 each) were preadsorbed with 
preimmune serum and reacted with 2-5 ffl of rabbit hy- 
perimmune sera overnight at 4 °. Specifically bound anti- 
gen was separated on denaturing polyacryiamide gels 
in the presence of prestained (Gibco BRL) or 14C-labeled 
(Amersham Buchler) marker proteins, incubated with the 
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intensifyer Amplify (Amersham Buchler), dried, and ex- 
posed to X-ray films (Kodak) or analyzed with a phospho- 
imager (Molecular Dynamics). 
Quantitation of proteins detected by Western blotting 
and RIPA 
Western blots were directly scanned using an Apple 
scanner with a Biosoft software program and the back- 
ground value was subtracted. Similarly, radioactive pro- 
teins specifically precipitated by HFV-specific antisera 
were quantitated for each HFV-specific gene product 
with a phosphoimager (Molecular Dynamics) and the 
background activity of pUC18-transfected cells was sub- 
tracted. For Western blots and RIPAs, viral protein ex- 
pression of pHSRV13-transfected cells was set to 100. 
The relative values for viral proteins expressed in 
pHSRVmTATA-transfected cells are given compared to 
those of pHSRV13-transfected cells. 
RNA extraction and purification 
Total RNA was harvested by cell lysis in guanidinium 
thiocyanate, sedimented through CsCI (Chirgwin et aL, 
1979), and digested with RNase-free DNase (Boehringer, 
Mannheim, FRG) or selected for poly(A) + mRNA as de- 
scribed recently (LOchelt et aL, 1994). Primer extensions 
were done with 5'-32P-labeled primer oligonucleotides 
9307a and 9485a (LOchelt et aL, 1993a, 1994). 
RESULTS 
Characterization of promoter II TATA box mutations 
in the HFV provirus 
To study the biological function of the internal pro- 
moter, the TATA box of HFV promoter II was changed 
from 5'-TATAAA-3' to 5'-GATCAA-3' in parental plas- 
mid pNNSEAP+ by POR-based mutagenesis to obtain 
pNNSEAPmTATA (Figs. 1B and 1D). The mutated pro- 
moter II TATA box in plasmid pNNSEAPmTATA was inserted 
into the infectious HFV DNA clone pHSRV13 (LOchelt 
et al., 1991). Two independent clones, pHSRVmTATA7 
and pHSRVmTATA19 were found to contain the expected 
mutations (Fig. 1D) that did not change the env reading 
frame (Figs. 1C and 1E). Promoter II TATA box mutants 
were used in transient transfection assays along with 
the wild-type proviral clone pHSRV13. Deletion mutant 
pHSRVAMN was included in this study since it lacks 
most of the env gene but retains the intact promoter II 
and should therefore not be capable for virus propaga- 
tion (Figs. 1A and 1F). 
Oomparative studies were performed using 0OS7 and 
FAB cells. COS7 cells of primate origin were used for 
the detection and characterization of the HFV internal 
promoter II and are efficiently transfectable by electro- 
poration. They are capable of synthesizing infectious HFV 
particles upon transfection with pHSRV13 (L6chelt et al., 
1991, 1993a). FAB cells are baby hamster kidney cells 
that contain the stably integrated HFV LTR promoter I 
upstream of the /3-gal gene. FAB cells are suitable for 
HFV infections, titrations and transfections as described 
recently (Yu and Linial, 1993). 
Characterization of promoter II TATA box mutants in 
COS cells 
Initially, COS7 cells were transfected with 10 #g 
pHSRV13, pHSRVmTATA7 and -19, or pHSRVAMN DNA 
(Fig. 1) along with 1 #g of the/g-gal expression plasmid 
pOMV/~gal. Cellular extracts were harvested and ana- 
lyzed for/~-gal expression and normalized aliquots were 
subjected to Western blotting using different HFV-spe- 
cific polyclonal antisera. 
Representative protein blots (Fig. 2) developed with a 
Bel 1/Bet-specific antiserum that recognize the 36-kDa Bel 
1 and the 56-kDa Bet proteins and a Bel 2/Bet-specific 
antiserum that recognize the 43-kDa Bel 2 and the Bet 
proteins showed that pHSRV13 expressed high amounts 
of Bet (solid arrow). The bands of 56 kDa (lanes 3 and 
4) that represent two independent electroporations were 
strongly expressed, whereas Bel 1 and Bel 2 (open arrow) 
were detectable at lower levels. Bet is specifically recog- 
nized by both antisera since Bet consists of an amino- 
terminal Bel 1 and a central and carboxy-terminal Bel 2 
domain. An expression pattern similar to that of wild-type 
was found for plasmid pHSRVAMN (lane 2). However, the 
amount of Bet expressed by pHSRVmTATA7 and 
pHSRVmTATA19 (lanes 5 and 6) was close to the limit of 
detection, whereas neither Bel 1 nor Bel 2 were visible 
even after prolonged staining. An analogous reduced anti- 
gen expression was also observed using Bel 1- or gag- 
specific sera showing an approximately 10-fold reduction 
in antigen expression by plasmids pHSRVmTATA when 
compared to pHSRV13 and pHSRVAMN (data not shown). 
This expression pattern was also observed when 
transfected 0OS7 cells were subjected to indirect immu- 
nofluorescence using the antisera mentioned above (data 
not shown). The differences in HFV gene expression were 
also detectable at the level of HFV mRNA by Northern 
blot analysis of poly(A)+-selected RNA isolated from 
transfected COS7 cells (data not shown). 
We next sought to find out whether the promoter II 
TATA box mutation affected virus infectivity. Cell-associ- 
ated and cell-free infectivities were harvested 42 hr after 
transfection with plasmids pHSRV13, pHSRVmTATA7 
and -19, and pHSRVAMN. Infectivity was assayed by 
titration on FAB cells using the/~-gal assay or by titration 
on HEL cells and subsequent counting of syncytia. In- 
fectivity was substantially higher when preparations of 
cell-associated virus were used as recently described 
(Yu and Linial, 1993). 
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FIG. 1. Schematic diagram of the HFV DNA genome. In A, the bent arrows mark the two HFV promoters, I and II; the differently shaded boxes 
represent he HFV genes. The Bet protein is formed by splicing. Part of the env sequence is enlarged to emphasize the precise location of the HFV 
internal promoter (B). HFV sequence between nt 9130 and 9201 in the 5' to 3' sense orientation. The HFV promoter II TATA box is underlined; the 
internal cap site at nt 9196 is indicated by a bent arrow (in bold). The cryptic start sites of transcription are shown by bent arrows (thin lines); a 
TATA box homolog upstream of these initiation sites is boxed. In C, part of the deduced protein sequence of the HFV env reading frame is shown 
in the three-letter code. (D) Sequence of the mutated promoter II TATA box introduced into plasmids pNNCATmTATA, pNNSEAPmTATA, and 
pHSRVmTATA. Mutated base residues are underlined. In E, the deduced amino acid sequence of the env reading frame of promoter II TATA box 
mutants is given in the three-letter code. (F) The deletion in the HFV env between the Mrol and Ndel sites (HFV nts 6962 to 8970) in plasmid 
pHSRVAMN is indicated by the corresponding restriction sites and the gap within the env gene. 
Plasmid pHSVR13 resulted in the synthesis of about 1 
X 104 blue cells/ml of cell-free HFV particles when ti- 
trated on FAB cells, Both plasmids pHSRVmTATA7 and 
pHSRVmTATA19 yielded an average of about 2 × 102 
blue cells/ml. The env  deletion mutant pHSRVAMN did 
not direct the synthesis of infectious HFV particles as 
expected due to the large deletion in the env  gene (Fig. 
1F). The titration described above was repeated several 
times with similar results, the infectivity of plasmid 
pHSRVmTATA is 50- to 100-fold reduced in comparison 
to wild-type plasmid pHSRV13. The difference in titer was 
not dependent on the mode of titration (FAB versus HEL 
cells) or the source of infectivity (cell-free or cell-associ- 
ated virus). 
Character izat ion of promoter II TATA box mutants in 
FAB ce l l s  
For further characterization of HFV promoter II TATA 
box mutants, FAB cells were used. FAB cells are permis- 
sive for HFV infection and capable of forming HFV-spe- 
cific syncytia. Furthermore, the transfection efficiency is 
comparable to 0©$7 cells and FAB ceils al low an easy 
and efficient assay for HFV infectivity and expression of 
the Bel 1 transactivator. Since FAB cells express fl-gal 
activity in the presence of Be[ 1, the CMV-IE promoter- 
directed luc construct pCMVluc was employed in order 
to standardize the transfection efficiency and extraction 
procedure. 
FAB cells were transfected with plasmids pHSRV13, 
pHSRVmTATA7 and -19, and pHSRVAMN in the pres- 
ence of 1 #g of pCMVluc DNA. Cells were harvested 
42 hr after transfection and aliquots of the cell culture 
supernatants were used for titrations. At the time of har- 
vest, virtually all cells except those transfected with plas- 
mid pHSRVAMN showed the formation of syncytia. Both 
the size and the number of syncytia in cultures 
transfected with wild-type pHSRV13 DNA were substan- 
tially larger than after transfection with either of the 
pHSRVmTATA clones. 
The titration of cell-free culture supernatants on either 
HEL  or FAB cells showed again that the infectivity ob- 
tained with pHSRV13 DNA was about 50-fold higher than 
that derived from transfections with pHSRVmTATA7 or 
-19. The titers for a representative titration of ceIFfree 
supernatants on FAB cells were as follows: pHSRV13, 
1.7 x 104 blue cells/ml; pHSRVmTATA, 3.0 x 102 blue 
cells/ml; pHSRVz&MN, blue cells not detectable. 
In parallel, the transfected cells were harvested, lysed, 
and assayed for luc activity. Luc activity varied only mini- 
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anti Bel 1 / Bet 
123456 
Bet "4- 
anti Bel 2 / Bet 
123456 
~ ~ Bet 
. . . .  <-- Bel 2 
(lanes 7 to 12) is located in the 5' part of be/ 1. Primer 
9307a should al low the detection of most, if not all pro- 
moter II transcripts, whereas primer 9485a should result 
in cDNAs of spliced and unspliced promoter II be/ 1"/ 
bet* transcripts (internal promoter I I-derived transcripts 
are marked by an asterisk, L6chelt et al., 1993a, 1994)• 
Fie• 2. Protein blot analysis of Bel 1/Bet- and Bel 2/Bet-specific pro- 
teins with different plasmids. Proteins expressed by plasmid 
pHSRVAMN (lane 2), pHSRV13 (lanes 3 and 4, representing two inde- 
pendent ransfections), pHSRVmTATA7 (lane 5), and pHSRVmTATA19 
(lane 6). 0OS7 cells were harvested 42 hr after transfectien and the 
amount of protein loaded was normalized to coexpressed #-galactivity. 
Proteins from nontransfected COS7 cells served as negative control 
(lane 1). The position of the 56-kDa Bet protein is given by a solid 
arrow, that of the 43-kDa Bel 2 protein by a thin arrow. The size of the 
proteins was calculated from the migration of the same protein markers 
as in Fig. 5. 
9307a 9485a 
GATC1 2 345  6 7 8 9101112GA TC 
really between different transfections, indicating that the 
transfection efficiency for each of the plasmids used was 
comparable• We then analyzed to which degree each of 
the different HFV proviruses was oapable of transactivat- 
ing the integrated, Bel - l -dependent HFV-LTR-#-gal con- 
struct of the FAB cells; i.e., the analysis should reveal 
the level of Bel 1 expression by wild-type and mutant 
proviruses. To this end, regular aliquots of luc extracts 
were subjected to /~-gal assays and the p-gal activity 
was normalized to coexpressed luc activity. The fol lowing 
relative values for each construct were found: pHSRV13, 
1.0; pHSRVAMN, 0.95; and pHSRVmTATA, 0.19, These 
experiments were repeated three times with similar re- 
sults. 
The pattern of gene expression was analyzed on the 
level of HFV-specific transcripts derived from each of the 
HFV provirus clones (data not shown)• Plasmid pHSRV13 
expressed high amounts of be l /bet  transcripts and much 
lower amounts of the other HFV mRNAs. Promoter II 
TATA box mutants pHSRVmTATA7 and -19 showed re- 
ductions in expression of the viral mRNAs. 
To study directly the utilization of the internal promoter 
II, transcripts directed by wild-type and mutant provirus- 
es were analyzed by primer extension experiments (Fig. 
3). RNA was harvested 42 hr after transfection of FAB 
cells with pHSRV13 (lanes 2 and 3 and 9 and 10, each 
pair representing two independent electroporations), 
pHSRVAMN (lanes 1 and 8), and pHSRVmTATA19 (lanes 
4 and 5 and 11 and 12, two independent ransfections). 
HFV anti-sense ol igonucleotide 9307a (lanes 1 to 6) is 
located at the 3' -end of exon 6/exon I and primer 9485a 
FIG. 3. Detection of spliced and unspliced be/ 1~bet-specific tran- 
scripts from various plasmids 42 hr after transfection. Plasmids 
pHSRVAMN (lanes 1 and 8), pHSRV13 (lanes 2, 3, 9, and 10; two 
independent transfectiens), and pHSRVmTATA19 (lanes 4, 5, 11, and 
12; two independent transfections) were transfected into FAB cells. 
RNA from untreated FAB cells was used as control (lanes 6 and 7). 
Primer extensions were done with antisense primer 9307a located at 
the 3'-end of exon 6, and primer 9485a located in the 5' end of the 
be/1 gene, 59 nt downstream of the majorbel 1~bet splice accepter. The 
reaction products ofthe primer extensions were analyzed in parallel to 
a sequencing reaction of a yeast gene (left handlanes G to C, indicating 
the ddNTP used) and of pHSRV13 DNIA with primer 9485a (right hand 
lanes G to C). The open arrows in the left margin point to the 6' end 
of cryptically initiated transcripts detected with primer 9307a (lanes 4 
and 5). The solid arrow on the left points to cDNAs 112 nt in length 
(lanes 1, 2, and 3), corresponding to promoter II t anscripts. The curved 
and short solid arrows in the right margin mark unspliced (only faintly 
visible) and spliced HFV promoter II be/ 1*~bet* transcripts detected 
with primer 9485a (lanes 8, 9, and 10). The open arrows in the right 
margin indicate the position of the spliced cryptic promoter tl transcripts 
for be/ 1~bet (lanes 11 and 12). The location of the primers were as 
described previously (LOchelt et aL, 1993a, 1994). 
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RNA from untreated FAB cells was used as negative 
control (lanes 6 and 7). The reaction products of the 
primer extensions were loaded on a sequencing gel next 
to dideoxy sequencing reactions (lanes G to C) of 
pHSRV13 DNA primed with oligonucleotide 9485a (right- 
hand side) or another sequencing reaction (left-hand 
side). 
Reactions with primer 9307a yielded predominant ex- 
tension products of about 112 nt in length with RNAfrom 
plasmids pHSRVz~MN and pHSRV13 (Fig. 3, left-hand 
side, solid arrow in lanes 1,2, and 3) that was not detect- 
able with RNA from untreated cells (lane 6). This cDNA 
corresponds to HFV promoter II transcripts (L0chelt et 
aL, 1993a). The 112-nt band was virtually absent in reac- 
tions with RNA from pHSRVmTATA19 (lanes 4 and 5). 
However, two minor double bands of 143/144 and 146/ 
147 nt in length (pair of open arrows, lanes 4 and 5) were 
present in transfections with pHSRVmTATA19 that also 
appeared faintly after transfection with nonmutated pro- 
moter II TATA box proviruses. Even upon longer expo- 
sure, bands of lower molecular mass specific for a partic- 
ular plasmid were not present. 
Extensions with primer 9485a (lanes 7 to 12, right-hand 
side of Fig. 3) resulted in spliced and unspliced be/ 1"/ 
bet* transcripts of 171 (solid horizontal arrow in lanes 8, 
9, and 10) and 290 nt (solid curved arrow in lanes 8, 9, 
and 10) with plasmids pHSVRAMN and pHSRV13. The 
bands of 290 nt became more intense upon longer expo- 
sure. The bands of 171 and 290 nt were almost absent in 
reactions with RNA from pHSRVmTATA19 transfections 
(lanes 11 and 12). Again, two double bands that were 
31/32 and 34/35 nt longer (pair of open arrows, right 
margin, lanes 11 and 12) were present in much lower 
concentrations corresponding to spliced transcripts of 
the cryptic promoter. Upon overexposure of the autora- 
diogram, faint bands of about 322 and 325 nt appeared in 
lanes 11 and 12 that most probably represent unspliced 
transcripts derived from the cryptic promoter. It is note- 
worthy that be/1~bet ranscripts from the 5'-LTR promoter 
(e.g., the 110-nt-long singly spliced LTR-derived be/ 1 
transcript) were clearly not detectable. 
Close examination of DNA sequences upstream of the 
promoter II cap site at HFV position 9196 (Fig. 1B, bold 
arrow) revealed that a TATA box homology exists at HFV 
nt 9134 (boxed sequence in Fig. 1B). The transcriptional 
start sites directed by this cryptic TATA box are marked 
by thin arrows that map to a HFV DNA sequence bor- 
dered by two G base residues at HFV nt 9160 and nt 
9164 (Fig. 1B). 
The expression of HFV proteins in transfected FAB 
cells was subsequently analyzed by RIPA and immu- 
noblotting with different HFV specific antisera. In all 
cases, the amount of antigen used was normalized to 
coexpressed luc activity. 
To compare directly the kinetics of antigen expression, 
cells transfected with the different DNA constructs were 
split into halves and labeled with [3~S]methionine and 
[35S]cysteine for RIPA from 24 to 29 hr and from 29 to 34 
hr after transfection. Cells were lysed directly at the end 
of the labeling period and normalized amounts of cell 
extracts were subjected to RIPA. Representative RIPAs 
performed with the Bel 1/Bet-specific (Fig. 4A) and an 
env-specific (Fig. 4B) antiserum are shown. The amount 
of Bet protein synthesized by pHSRV13 (lanes 1, 9, and 
4; two transfections were performed in parallel) was sub- 
stantially higher than that expressed by clones 
pHSRVmTATA7 and 19 (lanes 2, 10, and 5, respectively). 
The quantitation of specifically immunoprecipitated HFV 
proteins by means of a phospoimager revealed that 
pHSRVmTATA clones expressed 14 and 19% of Bet pro- 
tein synthesis of wild-type pHSRV13 (Table 1) upon label- 
ing from 24 to 29 and from 29 to 34 hr after transfection, 
respectively. The relative amount of Bet expression from 
clones pHSRVmTATA was lower for the sample labeled 
from 24 to 29 hr after transfection than for that labeled 
later. This holds true also for the env-specific proteins= 
the relative expression of the env precursor gp130 by 
pHSRVmTATA increased from 35 to 42%; that of TM even 
increased from 9 to 17%. Similar results were also ob- 
tained with Bel 1- and gag-specific antisera (Table 1). 
When FAB cells were labeled for 15 hr from 27 to 42 hr 
after transfection, HFV antigen expression was still 
higher in pHSRV13-transfected cells. However, HFV gene 
expression for pHSRVmTATA-transfected cells was in 
general significantly increased (Table 1), indicating that 
the mutation of the promoter II TATA box in clones of 
pHSRVmTATA negatively affected gene expression pre- 
dominantly early after transfection. Furthermore, the 
amount of HFV particles released from such cultures 
during this labeling period was almost identical or maxi- 
mally twice in pHSRV13-transfected culture (Table 1). 
To determine the net synthesis of HFV-specific pro- 
teins, immunoblots were performed with antigen prepa- 
rations harvested 42 hr after transfection (Fig. 5). Proteins 
from luc extracts of transfected cells were analyzed for 
the expression of Bel 1/Bet-specific (Fig. 5A) and gag- 
specific antigens (Fig. 5B). The reduction in Bel 1 expres- 
sion (open arrow in A) by clone pHSRVmTATA7 (lane 2) 
was concomitant with a reduced bet gene expression 
(solid arrow in A) in comparison to pHSRV/\MN and 
pHSRV13 (lanes 1 and 3). The reduction of Bel 1 expres- 
sion was about 12-fold, and that of Bet 8-fold when com- 
paring the intensities of bands obtained from transfec- 
tions with pHSRV13 and pHSRVmTATA7. The expression 
of the HFV gag gene precursor molecules of 74 and 78 
kDa (Fig. 5B) was reduced about 1O-fold in the promoter 
II TATA box mutant (compare lane 2 versus lane 3). The 
reduction in gag and be/genes was also detectable for 
protein samples derived from the high-speed pellet frac- 
tion (data not shown). 
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FIG. 4. RIPA experiments performed with Bel 1/Bet- (A) and env SU- and TM-specific sera .(B). FAB cells were transfected with pHSRV13 (lanes 
1 and 6 and 4 and 9, each pair representing one independent electroporation), pHSRVmTATA7 (lanes 2 and 10), pHSRVmTATA19 (lanes 5 and 7), 
and pUC18 (lanes 3 and 8). The cells were split directly after transfection into halves and labeled with [3~S]methionine and [35S]cysteine from 24 
to 29 hr or from 29 to 34 hr after transfection as indicated above the lanes. Normalized amounts of cellular extracts were used for specific 
precipitation of HFV proteins. The positions of the Bet protein in A and those of the nv gp130 precursor and the env SU proteins in B are given 
by arrows in the left margin. In lanes M, a 14C-labeled protein marker was separated; the molecular masses of the proteins are given in kDa. 
The results presented here were obtained with COS7 
and FAB. As gene expression and infectivity of mutant 
pHSRVmTATA were also severely impaired in HEL cells 
(data not shown), the dependence on a functional pro- 
moter II is not restricted to a certain cell type although it 
showed some minor differences between the cells used. 
Trans-complementation of HFV promoter  II TATA box 
mutant provirus wi th  bel  1 
We next analyzed whether  the reduced expression of 
the Bel 1 transactivator is responsible for the decreased 
HFV antigen expression by HFV proviruses containing 
the mutated TATA box. We transfected p lasmids pUC18, 
TABLE 1 
RELATIVE AMOUNTS OF HFV-SPECIFIO PROTEINS OBTAINED AFTER TRANS- 
FECTION OF FAB CELLS WITH PROMOTER II TATA BOX MUTANTS COMPARED 
TO pHSRV13 WILD-TYPE TRANSFECTED FAB CELLS a 
RIPA, labeling period after transfection b 
24-29 hr 29-34 hr 27-42 hr 
(%) (~) (%) 
Bell 8.3 7.1 50.0 
Bet 14.5 18.9 71.4 
p74/78gag 15.6 22.2 33.3 
gp130env 34.5 41.7 83.3 
gp70/p65env 9.3 16.9 27.0 
gp41env nd ° nd 8.5 
virion gp7Oenv nd nd 76.9 
virion gp41env nd nd 76.9 
virion p33gag nd nd 50.0 
a Data were quantitated as described under Materials end Methods 
and represent the relative expression of pr moter II TATA box mutant 
pHSRVmTATA; the expression of wild-type pHSRV13 DNA was set to 
100%. 
Data represent mean values of two transfections of pHSRV13 and 
pHSRVmTATA DNA done in parallel. 
cnd, not determined. 
pHSRV13, and pHSRVmTATA19 in the presence or ab- 
sence of a Bel 1 expression clone into FAB cells. Cells 
were  labeled with [35S]cysteine and methionine 24 to 32 
hr after transfection, lysed, and processed for RIPA 
assays. The amounts of cell lysates used for RIPAs were 
normal ized to coexpressed luc activity. RIPAs were per- 
formed with Bel 1/Bet-, integrase (Int)-, and Env-specific 
antisera. 
The RIPA analysis with the Bel 1/Bet-specif ic ant iserum 
showed that in the absence of Bel 1 the concentrat ion 
of the Bet protein (Fig. 6, solid arrow) synthesized by 
plasmid pHSRVmTATA19 (Fig. 6, lane 5) was about 5% 
of that expressed by pHSRV13 (lane 3) under the same 
condit ions (Table 2). Coexpress ion of plasmid pBCbel l  
that directs the expression of authentic Bel 1 and a trun- 
A M 1 2 3  B M 1 2 3  
200  200  ! 
97 " ~,'~ 97  • 
68  " ~,~' ,~ 68 . , ~ ~. .qF -Gag -,,o ~ <1.- Bet  
43  • ~ <- -Be l  1 43  
29  • ~ ::::: 29  
FiG. 5. Western blot analysis of FAB cell extracts harvested 42 hr 
after transfection with pHSRVAMN (lanes 1 ),pHSRVmTATA7 (lanes 2), 
and pHSRV13 (lanes 3). The amount of protein analysed was normal- 
ized to coexpressed luc activity. The transferred proteins w re reacted 
with a Bel 1/Bet-specific (A) and a gag-specific polyclonal antiserum 
(B). In A, the solid arrow points to the 56-kDa Bet, he thin arrow to the 
36-kDa: Bel 1 protein. The arrow in B marks the position of the 74/ 
78-kDagag-precursers. The molecular masses of prestained proteins 
separated in lanes M are given in the left margin, consisting of the
following proteins (from top), myosin (heavy chain), 200 kDa; phospho- 
rylase b, 97.4 kDa; bovine serum albumin, 68 kDa; ovalbumin, 43 kDa; 
carboanhydrase, 29 kDa; ~-Iactoglobulin, 18.4 kDa; lysozyme, 14.3 kDa. 
608 LOCHELT ET AL. 
1 2 3 4 5 6 M  
kDa 
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moter II. 
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FIG. 6. Detection of be/1~bet-specific proteins expressed in FAB cells 
transfected with the following plasmids: pUC18 plus pBC12CMV (lane 
1), pUC18 plus pBObeH (lane 2), pHSRV13 plus pBC12CMV (lane 3), 
pHSRV13 plus pBCbell (lane 4), pHSRVmTATA19 with pBC12CMV (lane 
5), and pHSRVmTATA19 plus pBCbell (lane 6). Cells were labeled with 
[35S]cysteine and methionine 24 to 32 hr after transfection, lysed, and 
normalized aliquots of the cell extracts were subjected to RIPAs with 
a Bel 1/Bet-specific antiserum. The solid arrow points o the 56-kDa 
Bet, the thin arrow to the truncated form of the Bet protein expressed 
from cotransfected plasmid pBObell. [14C]-Iabeled protein marker were 
separated in parallel (lane M); their molecular masses are given in 
kDa. 
cated version of Bet increased the expression of the 56- 
kDa Bet protein by plasmid pHSRV13 (lanes 4) only 
slightly in comparison to cotransfection with the vector 
backbone pBC12CMV (lane 3) and Table 2. However, 
ceexpression of Bel 1 increased Bet expression by plas- 
mid pHSRVmTATA19 (lane 6) about sevenfold. Cells 
transfected with pUC18 DNA (lanes 1 and 2) did not 
synthesize Bet. Cotransfection of pBCbell (lane 2) re- 
sulted in the synthesis of the 36-kDa Bel 1 protein (visible 
only upon longer exposure of the gel) and a truncated 
version of Bet (thin arrow) as observed in other cotrans- 
fections with pBObell (lanes 4 and 6). Similar observa- 
tions were also obtained with Env- and Int-specific anti- 
sera (Table 2). Remarkably, cotransfection of be/ 1 along 
with either wild-type or promoter II mutant proviruses 
resulted in a significantly elevated gene expression of 
LTR-dependent pol and env gene products, whereas the 
increase in bet gene expression was not as much pro- 
nounced. 
In summary, the xogenously added Bel 1 transactiva- 
tor shifted bet, pol, env, and gag (data not shown) gene 
expression by promoter II TATA box mutants approxi- 
mately to wild-type levels and even increased the expres- 
sion of structural genes by pHSRV13 wild-type provirus. 
This indicates that the decreased protein expression by 
plasmids pHSRVmTATA is predominantly due to be/ 1 
DISCUSSION 
The data presented here show that the internal HFV 
promoter II that directs the expression of functional Bel 
1 and Bet proteins plays an important role during HFV 
infection (L0chelt et aL, 1993a, 1994). Proviruses with a 
mutated promoter II TATA box expressed reduced 
amounts of HFV-specific proteins and transcripts and 
resulted in HFV progeny virus with a reduced infectivity. 
The reduced expression of HFV structural and accessory 
genes by plasmid pHSRVmTATA was restored by provid- 
ing Bel 1 in trans. Cryptic start sites of transcription lo- 
cated 32 to 35 nt 5' of cap site II were utilized by promoter 
II TATA box mutants instead of the original one at HFV 
nt 9196. 
The mutagenesis of the promoter II TATA box virtually 
abolished the utilization of the original promoter II cap 
site at HFV nt position 9196 for gene expression. How- 
ever, since be/ 1"/bet* mRNAs transcribed from cryptic 
start sites of transcription were detectable and since 
reporter gene plasmids pNNSEAPmTATA and pNNCAT- 
mTATA that carry the mutated promoter II TATA box 
showed a two- to threefold reduced basal and Bel 1- 
transactivated activity (data not shown), plasmids 
pHSRVmTATA can be considered only as promoter II 
"leaky" mutants. Nevertheless, the results obtained with 
these clones support the assumed critical role of the HFV 
promoter II for gene expression and infectivity (L0chelt et 
aL, 1993a,b, 1994; Mergia, 1994; Campbell eta/., 1994). 
The increased utilization of cryptic start sites of transcrip- 
tion in promoter II TATA box mutants resulted in be/ 1" / 
bet* transcripts with a slightly extended mRNA leader 
sequence. Utilization of the 5'LTR promoter I to generate 
be/ transcripts was not observed by means of primer 
extension experiments even when the promoter II was 
mutated (Fig. 3). Therefore, wild-type and mutant HFV 
proviruses directed only miniscule amounts of be/1 tran- 
TABLE 2 
RELATIVE AMOUNTS QF HFV-SPEoIFIC PROTEINS OBTAINED AFTER TRANSFEC- 
TION OF FAB CELLS WITH PROMOTER II TATA Box MUTANTS COMPARED TO 
pHSRV13 WILD-TYPE TRANSFECTBD FAB CELLS IN THE ABSENCE OR PRESENCE 
OF COTRANSFEOTED PLASMID pBCbell a 
Bet Pol p120 Env gp130 
(%) (%) (%) 
pHSRV13 plus pBC12CMV 100.0 100,0 100.0 
pHSRV13 plus pBQbell 137.5 268.1 297.6 
pH SRVmTATA19 plus pBC12CMV 4.8 4.4 16.8 
pHSRVmTATA19 plus pBObell 31.4 183.1 146.4 
a Data were quantitated as described under Materials and Methods; the 
expression of wild-type pHSRVl 3 DNA plus pBC12CMV was set to 100%. 
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scripts from the LTR promoter I, the majority of be/ 1 
mRNAs started at the promoter II or at its cryptic start 
sites (L6chelt et al., 1994). 
The limiting step during gene expression of promoter II 
TATA box mutajqts seems to be their reduced Bel 1 expres- 
sion, since cotransfection of be/ 1 and pHSRVmTATA DNA 
increased env, pol, and gag (data not shown) gene expres- 
sion comparable to that of the wild4ype HFV provirus. The 
fact that Bet expression was not completely restored by 
transcomplementation with be/1 supports the view that the 
be/genes are predominantly expressed from the internal 
promoter II. Since Bel 1 was shown to be absolutely re- 
quired for HFV gene expression and infectivity (L6chelt et 
al., 1991; Yu and Linial, 1993; Baunach eta/., 1993; Lee et 
al., 1994) and since HFV be/ 1" /bet*  transcripts were de- 
tected early after infection (LOchelt et al., 1994), it is likely 
that the internal promoter II is the early promoter for ex- 
pressing Bel 1 after provirus synthesis. This conclusion is 
supported bythe RIPA experiments where gene expression 
by plasmids pHSRVmTATA was shown to be more strongly 
reduced early after transfection. This indicates that the mu- 
tation of the promoter II in plasmids pHSRVmTATA resulted 
in concentrations of Bel 1 early after infection not sufficient 
for complete transactivation (L6chelt et al., 1994). This may 
lead to abortive transfections in HEL cells. Alternatively, the 
threshold levels of Bel 1 needed for efficient transactivation 
were reached much later when compared to cells 
transfected with the infectious pHSRV13 DNA (LOchelt et 
al., 1994). Consequently, the burst of viral gene expression 
was delayed in pHSRVmTATA transfected FAB cells and 
was not as high as that found in wild-type transfected cells. 
The initial Bel 1-independent ranscription of be/ 1 mRNAs 
by the internal promoter may be accomplished by its ele- 
vated basal activity when the LTR promoter I is present in 
cis (LOchelt et aL, 1993b). 
HFV DNA sequences upstream of nt -226 relative to 
the promoter II cap site seem not to be important for full 
activity of the internal promoter, since mutant pHSRVz~MN 
was virtually indistinguishable in be/, gag, and pol  gene 
expression compared to wild-type pHSRV13. As expected, 
this clone was incapable of syncytia formation and not 
infectious as the env gene was deleted. An analogous lack 
of structural gene expression or defects in packaging or 
virus maturation by pHSRVmTATA DNA are unlikely to 
cause its strongly reduced infectivity, since the amounts 
and composition of viral proteins of HFV particles released 
late after pHSRVmTATA transfection were similar to that 
obtained from wild-type transfected cells (Table 1). We 
therefore assume that the low infectivity of pHSRVmTATA 
provirus is primarily related to a reduced capacity to initiate 
gene expression by the mutated promoter II directly after 
infection. 
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